Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1993
10/20/1993EP0565536A1 Stabilized, potent grf analogs
10/20/1993EP0533795A4 Composition of and treatment with biologically active peptides having d-amino acid residues
10/20/1993EP0529065A4 Receptor-based screening methods for amylin agonists and antagonists
10/20/1993EP0398925B1 Growth inhibiting agent and the use thereof
10/20/1993EP0220241B1 Purified protein having angiogenic activity and methods of preparation
10/19/1993US5254801 Inducing male sterility for hybrid seed production, cell ablation, counter-negative selection; genetic engineering
10/19/1993US5254800 Tomato plants and cells containing pTOM36 antisense constructs
10/19/1993US5254799 Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants
10/19/1993US5254673 Purification of zein from corn gluten meal
10/19/1993US5254672 Synthetic peptides which contain sequences from factor VIIa, and the use thereof
10/19/1993US5254671 Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
10/19/1993US5254535 Composition and treatment with biologically active peptides and antibiotic
10/19/1993US5254534 Adjuvant for cancer immunotherapy
10/19/1993US5254532 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
10/19/1993US5254463 Method for expression of bovine growth hormone
10/19/1993US5254462 Genetic engineering
10/19/1993US5254459 Nucleotide and amino acid sequences of protein MTP40 of M. tuberculosis and synthetic peptides derived therefrom
10/19/1993US5254350 Using a metal chelator
10/19/1993CA1323465C Process for producing bovine lactoferrin in high purity
10/19/1993CA1323317C Production of fibroblast growth factor
10/18/1993CA2094177A1 Derivatives of adipogenesis inhibitory factor, their preparation and their use
10/18/1993CA2091944A1 Analysis of hemoglobin variants by capillary zone electrophoresis
10/15/1993CA2093866A1 Methods of inhibiting the growth of multidrug resistant tumors
10/15/1993CA2087787A1 Cloning and characterization of a gene, inducible by cytokines
10/14/1993WO1993020442A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
10/14/1993WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993WO1993020242A1 Encoded combinatorial chemical libraries
10/14/1993WO1993020238A2 Amplification of human mdm2 gene in human tumors
10/14/1993WO1993020237A1 Homology cloning
10/14/1993WO1993020229A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN
10/14/1993WO1993020228A1 Novel, physiologically active protein and hemopoietic stem cell growth promoter
10/14/1993WO1993020227A1 Method of multiplex ligase chain reaction
10/14/1993WO1993020220A1 Non-infectious hiv particles and uses therefor
10/14/1993WO1993020219A1 Control and/or prevention of binding of nf-kb/rel/dorsal (nrd) family proteins to dna
10/14/1993WO1993020217A1 Plant virus vector, plasmid, method of expressing foreign gene, and method of acquiring foreign gene product
10/14/1993WO1993020216A1 Oil-body protein cis-elements as regulatory signals
10/14/1993WO1993020212A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA
10/14/1993WO1993020210A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993WO1993020208A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol
10/14/1993WO1993020204A1 Monomeric platelet-derived growth factor and prevention of stenosis or restenosis
10/14/1993WO1993020203A2 Stability-enhanced variants of parathyroid hormone
10/14/1993WO1993020202A1 Decorin fragments and methods of inhibiting cell regulatory factors
10/14/1993WO1993020201A1 GAP-ASSOCIATED PROTEIN p190 AND TRANSDUCTION
10/14/1993WO1993020200A1 Modified cells and method of treatment
10/14/1993WO1993020199A1 Human gonadotropin receptor (fsh receptor)
10/14/1993WO1993020197A1 Stem cell proliferation factor
10/14/1993WO1993020196A1 Cloning, expression and uses of a novel secreted protein, f-spondin
10/14/1993WO1993020189A1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
10/14/1993WO1993020188A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus
10/14/1993WO1993020187A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
10/14/1993WO1993020107A1 Recombinant active forms of ecef, proteins that associate therewith, and uses thereof
10/14/1993WO1993020106A1 Protein cellular factor useful for regulating gene expression
10/14/1993WO1993020104A1 Monoclonal antibodies against a carbohydrate-dependent epitope related to the v2 region of hiv-1 gp120
10/14/1993WO1993020103A2 Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification
10/14/1993WO1993020102A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
10/14/1993WO1993020098A1 Process for preparing modified proteins
10/14/1993WO1993020095A1 Antisense oligonucleotide inhibition of papillomavirus
10/14/1993WO1993020093A1 Hybrid human/porcine factor viii
10/14/1993WO1993020079A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
10/14/1993WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same
10/14/1993WO1993020070A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
10/14/1993WO1993020067A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993WO1993020064A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
10/14/1993WO1993020049A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels
10/14/1993WO1993020048A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
10/14/1993WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
10/14/1993WO1993019784A1 Novel endothelial adhesion molecule for monocytes
10/14/1993WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1
10/14/1993WO1993019781A1 Vaccines containing non-ionic surfactant vesicles
10/14/1993WO1993019779A1 Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
10/14/1993WO1993019777A1 Fusion proteins comprising tumor necrosis factor receptor
10/14/1993WO1993019775A1 Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins
10/14/1993WO1993019772A1 A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen
10/14/1993WO1993019768A1 Self-assembling polynucleotide delivery system
10/14/1993WO1993019767A1 Cd28 pathway immunoregulation
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1993019604A1 Nematocidal bacillus thuringiensis biopesticide
10/14/1993WO1993019603A1 Prokaryotes including dna encoding bacteriophage immunity
10/14/1993WO1993019591A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/14/1993WO1993017118A3 Defective packaging non-oncoviral vectors based on mpmv and hiv
10/14/1993WO1993017110A3 A recombinant hepatitis c virus polypeptide
10/14/1993WO1993014208A3 Hepatitis e virus vaccine and method
10/14/1993WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
10/14/1993CA2133758A1 A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen
10/14/1993CA2133662A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993CA2133443A1 Cloning, expression and uses of a novel secreted protein, f-spondin
10/14/1993CA2133220A1 Method of multiplex ligase chain reaction
10/14/1993CA2133075A1 CD28 Pathway Immunoregulation
10/14/1993CA2132949A1 Stability-enhanced variants of parathyroid hormone
10/14/1993CA2132859A1 Decorin fragments and methods of inhibiting cell regulatory factors
10/14/1993CA2132624A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993CA2132516A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
10/14/1993CA2132456A1 Nematocidal bacillus thuringiensis biopesticide
10/14/1993CA2132446A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
10/14/1993CA2132445A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
10/14/1993CA2132342A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
10/14/1993CA2132341A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993CA2132340A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivatives conjugates and labels
10/14/1993CA2132339A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels
10/14/1993CA2131727A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
1 ... 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 ... 2916